MyAverix Finance
F · Healthcare
AELIS FARMA SAS EO -004 (69O)
Biotechnology
AELIS FARMA SAS EO -004 (69O) is listed on F in the Healthcare sector. Industry: Biotechnology. As of 2026-05-23, reported P/E ratio is 25.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for 69O
AELIS FARMA SAS EO -004 (69O) — FAQ
What is 69O's P/E ratio?
The price-to-earnings (P/E) ratio for AELIS FARMA SAS EO -004 (69O) is 25.00 (data as of 2026-05-23).
Does AELIS FARMA SAS EO -004 pay a dividend?
Dividend yield is not available in the current snapshot for AELIS FARMA SAS EO -004 (69O). Check the MyAverix Finance app for the latest dividend data.
What sector is AELIS FARMA SAS EO -004 in?
AELIS FARMA SAS EO -004 (69O) is classified in the Healthcare sector (Biotechnology industry).
What exchange is 69O listed on?
69O is listed on F.
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.